Medroxyprogesterone acetate and meningioma: a global issue
- PMID: 40207201
- PMCID: PMC11979271
- DOI: 10.3389/fgwh.2025.1470539
Medroxyprogesterone acetate and meningioma: a global issue
Keywords: contraception; depot medroxyprogesterone acetate; meningioma; progestogen; public health.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- United Nations. Contraceptive Use by Method 2019: Data Booklet. New York: UN; (2019). 10.18356/1bd58a10-en - DOI
-
- Halpern V, Brache V, Taylor D, Lendvay A, Cochón L, Jensen JT, et al. Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera. Fertil Steril. (2021) 115:1035–43. 10.1016/j.fertnstert.2020.11.002 - DOI - PMC - PubMed
-
- United Nations. World Contraceptive Use | Population Division. (2022). Available online at: https://www.un.org/development/desa/pd/data/world-contraceptive-use (accessed July 17, 2024).
-
- United Nations. Family Planning and the 2030 Agenda for Sustainable Development (Data Booklet). New York: United Nations; (2019). 10.18356/e154e49d-en - DOI
LinkOut - more resources
Full Text Sources
